Microbial metabolites as mimickers of human molecules – Nature.com
|
Microbial metabolites as mimickers of human molecules
Nature.com A new study has found that gut bacteria produce metabolites — N-acyl amides — that interact with G protein-coupled receptors (GPCRs) and mimic human GPCR ligands, providing clues to how microbial metabolites might regulate host physiology. The links … |
Scientific American |
How Close Are We to a Lifelong Cure for Cancer?
Scientific American He developed methods to engineer a patient’s T cells into so-called chimeric antigen receptor T (CAR–T) cells, which recognize and kill a person’s unique cancer. This is called immunotherapy — training a person’s body to kill disease. One treatment … |
The Cardiology Advisor (registration) |
High Levels of Stem Cell Factor Linked to Reduced CV Events
The Cardiology Advisor (registration) HealthDay News — High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published in the Journal of Internal Medicine. Harry Björkbacka, PhD, from Lund University in Sweden … |
The Cardiology Advisor (registration) |
High Levels of Stem Cell Factor Linked to Reduced CV Events
The Cardiology Advisor (registration) HealthDay News — High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published in the Journal of Internal Medicine. Harry Björkbacka, PhD, from Lund University in Sweden … |
Endpoints News |
Gene therapy startup Rocket Pharma reverse merges with troubled Inotek after $25M raise
Endpoints News Two months after Inotek shares cratered following the second conclusive failure of its lead glaucoma drug — scuttling its share price — the Lexington, MA-based biotech $ITEK has become a reverse merger shell for a gene therapy company called Rocket … Pharma Companies Merge to Advance Gene Therapy PipelineRare Disease Report Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in …Business Wire (press release) |
|
Parkinson’s Institute Team Uses CRISPR/Cas9 Capture and PacBio Sequencing to ID Repeat Expansions
GenomeWeb SAN FRANCISCO (GenomeWeb) – Researchers from the Parkinson’s Institute and Clinical Center in Sunnyvale, California have shown that a CRISPR/Cas9-based capture enrichment technique, combined with sequencing on Pacific Biosciences’ platform, … |